Observational Study
Copyright ©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 116-123
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.116
Table 1 Percentage distribution of demographic and disease characteristics of patients with primary hepatocellular carcinoma at Cho Ray Hospital, Ho Chi Minh City, Vietnam, 2010 to 2016
Characteristic2010 (n = 2793)2011 (n = 3111)2012 (n = 3349)2013 (n = 3471)2014 (n = 3494)2015 (n = 3804)2016 (n = 4069)Total (n = 24091)P value
Male gender82.682.7782.2380.4481.281.282.1381.760.17
Age (yr)
≤ 4010.318.949.148.587.767.67.778.49< 0.0001
41-5019.318.5817.4417.2617.3217.4316.7617.64
51-6030.6830.5729.2330.8329.2829.8629.2929.92
61-7021.4822.624.3723.2226.2426.6327.8924.86
> 7018.2219.3219.8320.1119.418.4818.2819.08
Advanced disease stage40.5743.6840.5237.6540.7840.7541.6840.790.76
HBsAg and anti-HCV testing available (n)1n = 2505n = 2405n = 2773n = 3153n = 3225n = 3616n = 3907n = 21584< 0.0001
HBV infection61.7269.9466.3560.159.6960.8760.2362.28
HCV infection24.7927.3228.9625.0627.1325.0624.9826
HBV and HCV coinfection2.712.742.523.042.952.412.462.68
Non-HBV or HCV liver disease10.7802.1611.810.2311.6712.348.97
Table 2 Distribution of serum alpha-fetoprotein levels in patients with hepatocellular carcinoma, 2010 to 2016
AFP level (ng/mL)2010 (n = 2793)2011 (n = 3111)2012 (n = 3349)2013 (n = 3471)2014 (n = 3494)2015 (n = 3804)2016 (n = 4069)Total (n = 24091)
< 2023.2422.5321.5926.2222.4122.3223.9923.21
> 20-10015.4314.1415.1713.7115.0014.5414.4814.62
> 100-2006.305.375.115.366.706.346.415.96
> 200-4005.875.635.325.305.385.815.975.62
> 40047.6550.5050.8246.9948.2049.5047.5348.72
Not recorded1.501.832.002.422.321.51.621.88